GIRGENTI STEVEN
SEC CIK 1055530 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | Executive COB, Dir | 1.08M | — | — | 13 | 2022-08-31 | 2025-01-10 |
Most active insiders at BIAF, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
GIRGENTI STEVEN made no open-market trades at BIAF in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | 2025-01-10 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $0.00 | +14.8K | 1.08M | +1% | $0 | |
| 2024-07-02 | 2024-07-01 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $0.00 | +33.8K | 1.07M | +3% | $0 | |
| 2024-06-14 | 2024-06-12 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $0.00 | +8,296 | 1.03M | +0.8% | $0 | |
| D | 2024-04-24 | 2024-04-03 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Dir | M - OptEx | $1.16 | +64.8K | 1.06M | +7% | +$75.2K |
| D | 2024-04-24 | 2024-04-03 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Dir | F - Tax | $2.24 | -33.4K | 1.02M | -3% | -$74.9K |
| 2024-03-29 | 2024-02-16 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $1.52 | +39.5K | 991.8K | +4% | +$60.0K | |
| 2024-02-02 | 2024-01-31 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $0.00 | +11.9K | 952.3K | +1% | $0 | |
| M | 2024-01-24 | 2023-10-01+ | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $1.53 | +24.5K | 940.3K | +3% | +$37.5K |
| M | 2023-08-11 | 2023-01-01+ | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $2.13 | +54.7K | 869.3K | +7% | +$116.3K |
| M | 2023-07-06 | 2023-01-01+ | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | A - Grant | $1.98 | +28.4K | 889.5K | +3% | +$56.3K |
| DMI | 2022-11-08 | 2022-09-06 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | C - Cnv Deriv | $4.71 | +8,955 | 8,955 | New | +$42.2K |
| D | 2022-11-08 | 2022-08-31 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | P - Purchase | — | +40.9K | 861.1K | +5% | — |
| DM | 2022-11-08 | 2022-09-06 | BIAF | bioAffinity Technologies, Inc. | GIRGENTI STEVEN | Executive COB, Dir | C - Cnv Deriv | $4.05 | +570.9K | 405.9K | New | +$2.31M |
Purchase Sale Sale after option exercise All abbreviations